Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Diana Zabini (Toronto, Canada), Diana Zabini, Andras Kapus, Wolfgang Kuebler. SMAD3 regulation contributes to lung vascular remodeling in pulmonary arterial hypertension. Eur Respir J 2015; 46: Suppl. 59, 3496

Member's Comments

No comment yet.

Related content which might interest you: Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Crosstalk between endothelin-1 and BMPR2 signaling contributes to smooth muscle cell hyperplasia Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Link between airway inflammation and remodeling: TNFα induces airway smooth muscle cell proliferation via an ET1/GMCSF/IL6 network Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Allergic asthma induce opposite changes in the expression of caveolin-1 and cavin-2 in airway and vascular pulmonary smooth muscle Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 The hypoxia-induced miR-130 increases proliferation of pulmonary arterial smooth muscle cells by targeting the tumour suppressor CDKN1A (p21) Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007